City Therapeutics Shares Surge 28% in Nasdaq Trading Debut

Key Facts

City Therapeutics shares surged 28% in their trading debut following a $200 million initial public offering. The company's stock began trading on the Nasdaq after pricing its upsized offering at $18.00 per share.

Investing.com reported that the company increased the size of the deal beyond previous expectations due to strong investor demand. By raising $200 million in capital, the company aims to secure funding for its ongoing operations and growth in the public markets.